Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$137.00K$137.00Kderivedno prior Q4 2015 on file Net Income-$3.58M-$3.58MderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$3,472,000N/M Operating Cash Flowderived-$2,515,000N/M Margins · derivedOperating margin-2534.3%
Net margin-2614.6%
ended Dec 31, 2016 · filed Mar 30, 2017 · 89 d after period end